Stay updated on ARGX-110 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 in Advanced Malignancies Clinical Trial page.

Latest updates to the ARGX-110 in Advanced Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe ARGX-110 study record is now available, including its completed status, participant eligibility, treatment arms, study outcomes, and locations.SummaryDifference50%

- Check13 days agoChange DetectedThe site revision indicator changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice was added above the 403 page announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating that the record is inaccessible and no trial details can be viewed from this page.SummaryDifference18%

Stay in the know with updates to ARGX-110 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 in Advanced Malignancies Clinical Trial page.